APO RESEARCH · REPORT
Drugs for Malaria
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Product & engineering
Understand the product.
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
Selected research
Market Structure
Global Drugs for Malaria Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.
Read the full market overview
Report Includes
This report provides an overview of the global Drugs for Malaria market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Drugs for Malaria and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Drugs for Malaria revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drugs for Malaria market size, projected growth trends, production technologies, key applications, and end-use industries.
Drugs for Malaria Segment by Company
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Drugs for Malaria Segment by Type
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Drugs for Malaria Segment by Application
Prevention
Treatment
Others
Drugs for Malaria Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drugs for Malaria in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs for Malaria industry.
Chapter 3: Detailed analysis of Drugs for Malaria companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Malariarevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
Applications
- Prevention
- Treatment
- Others
Companies covered
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Aryl Aminoalcohol Compounds
- 1.2.3 Antifolate Compounds
- 1.2.4 Artemisinin Compounds
- 1.3 Market Analysis by Application
- 1.3.1 Global Drugs for Malaria Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Prevention
- 1.3.3 Treatment
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Drugs for Malaria Growth Trends by Region
- 1.5.1 Global Drugs for Malaria Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Drugs for Malaria Market Size by Region (2021-2026)
- 1.5.3 Drugs for Malaria Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Drugs for Malaria Market Dynamics
- 2.1 Drugs for Malaria Industry Trends
- 2.2 Drugs for Malaria Industry Drivers
- 2.3 Drugs for Malaria Industry Opportunities and Challenges
- 2.4 Drugs for Malaria Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Drugs for Malaria Revenue by Company (2021-2026)
- 3.2 Global Drugs for Malaria Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Drugs for Malaria Key Company Head office and Area Served
- 3.4 Global Drugs for Malaria Company, Product Type & Application
- 3.5 Global Drugs for Malaria Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Drugs for Malaria Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2025
- 3.6.3 2025 Drugs for Malaria Tier 1, Tier 2, and Tier 3
4 Drugs for Malaria Market by Type
- 4.1 Global Drugs for Malaria Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Drugs for Malaria Market Size by Type (2021-2032)
- 4.3 Global Drugs for Malaria Market Size Share by Type (2021-2032)
5 Drugs for Malaria Market by Application
- 5.1 Global Drugs for Malaria Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Drugs for Malaria Market Size by Application (2021-2032)
- 5.3 Global Drugs for Malaria Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Cipla
- 6.1.1 Cipla Company Information
- 6.1.2 Cipla Business Overview
- 6.1.3 Cipla Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Cipla Drugs for Malaria Product Portfolio
- 6.1.5 Cipla Recent Developments
- 6.2 Guilin Pharmaceutical
- 6.2.1 Guilin Pharmaceutical Company Information
- 6.2.2 Guilin Pharmaceutical Business Overview
- 6.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
- 6.2.5 Guilin Pharmaceutical Recent Developments
- 6.3 IPCA Laboratories
- 6.3.1 IPCA Laboratories Company Information
- 6.3.2 IPCA Laboratories Business Overview
- 6.3.3 IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
- 6.3.5 IPCA Laboratories Recent Developments
- 6.4 GlaxoSmithKline
- 6.4.1 GlaxoSmithKline Company Information
- 6.4.2 GlaxoSmithKline Business Overview
- 6.4.3 GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
- 6.4.5 GlaxoSmithKline Recent Developments
- 6.5 Mylan Labs
- 6.5.1 Mylan Labs Company Information
- 6.5.2 Mylan Labs Business Overview
- 6.5.3 Mylan Labs Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Mylan Labs Drugs for Malaria Product Portfolio
- 6.5.5 Mylan Labs Recent Developments
- 6.6 Roche
- 6.6.1 Roche Company Information
- 6.6.2 Roche Business Overview
- 6.6.3 Roche Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Roche Drugs for Malaria Product Portfolio
- 6.6.5 Roche Recent Developments
- 6.7 Novartis
- 6.7.1 Novartis Company Information
- 6.7.2 Novartis Business Overview
- 6.7.3 Novartis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Novartis Drugs for Malaria Product Portfolio
- 6.7.5 Novartis Recent Developments
- 6.8 Sanofi Aventis
- 6.8.1 Sanofi Aventis Company Information
- 6.8.2 Sanofi Aventis Business Overview
- 6.8.3 Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
- 6.8.5 Sanofi Aventis Recent Developments
- 6.9 Ajanta Pharma
- 6.9.1 Ajanta Pharma Company Information
- 6.9.2 Ajanta Pharma Business Overview
- 6.9.3 Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
- 6.9.5 Ajanta Pharma Recent Developments
7 North America
- 7.1 North America Drugs for Malaria Market Size (2021-2032)
- 7.2 North America Drugs for Malaria Market Size by Type
- 7.2.1 North America Drugs for Malaria Market Size by Type (2021-2026)
- 7.2.2 North America Drugs for Malaria Market Size by Type (2027-2032)
- 7.2.3 North America Drugs for Malaria Market Share by Type (2021-2032)
- 7.3 North America Drugs for Malaria Market Size by Application
- 7.3.1 North America Drugs for Malaria Market Size by Application (2021-2026)
- 7.3.2 North America Drugs for Malaria Market Size by Application (2027-2032)
- 7.3.3 North America Drugs for Malaria Market Share by Application (2021-2032)
- 7.4 North America Drugs for Malaria Market Size by Country
- 7.4.1 North America Drugs for Malaria Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Drugs for Malaria Market Size by Country (2021-2026)
- 7.4.3 North America Drugs for Malaria Market Size by Country (2027-2032)
- 7.4.4 North America Drugs for Malaria Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Drugs for Malaria Market Size (2021-2032)
- 8.2 Europe Drugs for Malaria Market Size by Type
- 8.2.1 Europe Drugs for Malaria Market Size by Type (2021-2026)
- 8.2.2 Europe Drugs for Malaria Market Size by Type (2027-2032)
- 8.2.3 Europe Drugs for Malaria Market Share by Type (2021-2032)
- 8.3 Europe Drugs for Malaria Market Size by Application
- 8.3.1 Europe Drugs for Malaria Market Size by Application (2021-2026)
- 8.3.2 Europe Drugs for Malaria Market Size by Application (2027-2032)
- 8.3.3 Europe Drugs for Malaria Market Share by Application (2021-2032)
- 8.4 Europe Drugs for Malaria Market Size by Country
- 8.4.1 Europe Drugs for Malaria Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Drugs for Malaria Market Size by Country (2021-2026)
- 8.4.3 Europe Drugs for Malaria Market Size by Country (2027-2032)
- 8.4.4 Europe Drugs for Malaria Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Drugs for Malaria Market Size (2021-2032)
- 9.2 China Drugs for Malaria Market Size by Type
- 9.2.1 China Drugs for Malaria Market Size by Type (2021-2026)
- 9.2.2 China Drugs for Malaria Market Size by Type (2027-2032)
- 9.2.3 China Drugs for Malaria Market Share by Type (2021-2032)
- 9.3 China Drugs for Malaria Market Size by Application
- 9.3.1 China Drugs for Malaria Market Size by Application (2021-2026)
- 9.3.2 China Drugs for Malaria Market Size by Application (2027-2032)
- 9.3.3 China Drugs for Malaria Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Drugs for Malaria Market Size (2021-2032)
- 10.2 Asia Drugs for Malaria Market Size by Type
- 10.2.1 Asia Drugs for Malaria Market Size by Type (2021-2026)
- 10.2.2 Asia Drugs for Malaria Market Size by Type (2027-2032)
- 10.2.3 Asia Drugs for Malaria Market Share by Type (2021-2032)
- 10.3 Asia Drugs for Malaria Market Size by Application
- 10.3.1 Asia Drugs for Malaria Market Size by Application (2021-2026)
- 10.3.2 Asia Drugs for Malaria Market Size by Application (2027-2032)
- 10.3.3 Asia Drugs for Malaria Market Share by Application (2021-2032)
- 10.4 Asia Drugs for Malaria Market Size by Country
- 10.4.1 Asia Drugs for Malaria Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Drugs for Malaria Market Size by Country (2021-2026)
- 10.4.3 Asia Drugs for Malaria Market Size by Country (2027-2032)
- 10.4.4 Asia Drugs for Malaria Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Drugs for Malaria Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Drugs for Malaria Market Size by Type
- 11.2.1 South America, Middle East & Africa Drugs for Malaria Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Drugs for Malaria Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Drugs for Malaria Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Drugs for Malaria Market Size by Application
- 11.3.1 South America, Middle East & Africa Drugs for Malaria Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Drugs for Malaria Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Drugs for Malaria Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Drugs for Malaria Market Size by Country
- 11.4.1 South America, Middle East & Africa Drugs for Malaria Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Drugs for Malaria Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Drugs for Malaria Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Drugs for Malaria Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst